Soleus Capital Management’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,362,026
| Closed | -$833K | – | 100 |
|
|
2025
Q3 | $833K | Buy |
4,362,026
+2,100,000
| +93% | +$2.52M | 0.04% | 80 |
|
|
2025
Q2 | $3.85M | Hold |
2,262,026
| – | – | 0.25% | 60 |
|
|
2025
Q1 | $3.57M | Hold |
2,262,026
| – | – | 0.26% | 55 |
|
|
2024
Q4 | $4.05M | Sell |
2,262,026
-2,026,141
| -47% | -$6.45M | 0.25% | 57 |
|
|
2024
Q3 | $26M | Buy |
4,288,167
+77,630
| +2% | +$426K | 2.01% | 15 |
|
|
2024
Q2 | $22.1M | Buy |
4,210,537
+620,979
| +17% | +$3.95M | 1.95% | 16 |
|
|
2024
Q1 | $30.5M | Sell |
3,589,558
-738,064
| -17% | -$6.44M | 2.26% | 10 |
|
|
2023
Q4 | $28.6M | Buy |
4,327,622
+40,528
| +0.9% | +$200K | 3.17% | 10 |
|
|
2023
Q3 | $13.2M | Buy |
4,287,094
+85,000
| +2% | +$245K | 1.22% | 30 |
|
|
2023
Q2 | $11.3M | Buy |
4,202,094
+56,977
| +1% | +$167K | 1.26% | 22 |
|
|
2023
Q1 | $12.3M | Buy |
4,145,117
+275,725
| +7% | +$810K | 1.27% | 23 |
|
|
2022
Q4 | $9.75M | Buy |
3,869,392
+1,228,853
| +47% | +$3.53M | 1.4% | 25 |
|
|
2022
Q3 | $4.81M | Sell |
2,640,539
-1,528,260
| -37% | -$4.03M | 0.65% | 43 |
|
|
2022
Q2 | $13.1M | Sell |
4,168,799
-55,000
| -1% | -$307K | 2.05% | 13 |
|
|
2022
Q1 | $26.1M | Buy |
4,223,799
+698,342
| +20% | +$6.14M | 3.37% | 3 |
|
|
2021
Q4 | $50.1M | Buy |
3,525,457
+657,434
| +23% | +$7.32M | 5.01% | 4 |
|
|
2021
Q3 | $22.9M | Buy |
2,868,023
+629,919
| +28% | +$10M | 3.58% | 7 |
|
|
2021
Q2 | $63.9M | Buy |
2,238,104
+168,052
| +8% | +$4.88M | 9.83% | 2 |
|
|
2021
Q1 | $60.1M | Sell |
2,070,052
-305,629
| -13% | -$7.1M | 10.84% | 2 |
|
|
2020
Q4 | $28.3M | Buy |
2,375,681
+548,701
| +30% | +$3.86M | 3.74% | 3 |
|
|
2020
Q3 | $12.6M | Sell |
1,826,980
-255,205
| -12% | -$1.73M | 6.68% | 1 |
|
|
2020
Q2 | $12.9M | Buy |
2,082,185
+1,764
| +0.1% | +$8.36K | 7.36% | 2 |
|
|
2020
Q1 | $8.32M | Buy |
2,080,421
+446,052
| +27% | +$2.24M | 9.68% | 1 |
|
|
2019
Q4 | $8.99M | Buy |
+1,634,369
| New | +$7.6M | 8.67% | 2 |
|
Soleus Capital Management's EPIX Position: Q4 2025 in Review
Soleus Capital Management sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 4,362,026 shares — an estimated $833K sold.
Soleus Capital Management first reported a position in EPIX in Q4 2019 and held it in 24 quarters. The position peaked at $63.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- Soleus Capital Management reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- Soleus Capital Management sold 4,362,026 ESSA Pharma shares in Q4 2025, an estimated $833K.
- Soleus Capital Management first reported a position in ESSA Pharma in Q4 2019 and held it in 24 quarters.
- Soleus Capital Management's ESSA Pharma position peaked at $63.9M in Q2 2021.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on Soleus Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.